3.7. Analysis.
Comparison 3 Amifostine versus no treatment/placebo, Outcome 7 Overall survival ‐ narrative data.
Overall survival ‐ narrative data | ||||
---|---|---|---|---|
Study | Time point | Amifostine | Control | Comments |
Haddad 2009 | Median follow‐up 34 months after radiotherapy, minimum 26 months | "No differences noted" | ||
Jellema 2006 | 24 months | 3 times weekly = 84% 5 times weekly = 58% |
70% | Reported narratively rather than as a risk ratio due to differing results in the amifostine arms |